Skip to content

Brimonidine Tartrate Impurity

Brimonidine Tartrate Impurity

Product Description
CAT No.
ALN-B026017
CAS No.
NA
Mol. F.
C15H12BrN5O4
Mol. Wt.
406.2
Stock
Please Inquire
RFQ
Chemical Name : 9-(5-Bromoquinoxalin-6-yl)-6,7-dihydroxy-2,6,7,9-tetrahydro-3H-imidazo[1,2-a][1,3]diazepine-5,8-dione
Smiles : BrC1=C2C(N=CC=N2)=CC=C1N3C4=NCCN4C(C(O)C(O)C3=O)=O
Inchi : InChI=1S/C7H8N4O3/c1-10-3-4(8-6(10)13)9-7(14)11(2)5(3)12/h1-2H3,(H,8,13)(H,9,14)/i2D3

Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma

B.Chianga1Y.C.Kimb1A.C.Dotyc12H.E.GrossniklausdS.P.SchwendemancM.R.PrausnitznJournal of Controlled Release Volume 228, 28 April 2016, Pages 48-57

Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma

Jianguo Sun, Yuan Lei, Zhaoxing Dai∥, Xi Liu, Taomin Huang, Jihong Wu, Zhi Ping XOrcid, and Xinghuai Sun – ACS Appl. Mater. Interfaces 2017, 9, 9, 7990–7999

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems

Jianguo Sun, Xiuwen Zhang & Taomin Huang – Chemistry Central Journal volume 11, Article number: 62 (2017)

Request For Quotation

Related Products